Anal Fistula
2
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
AB
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
TakedaASCs
Angiocrine BioscienceE-CEL UVEC
Clinical Trials (2)
Total enrollment: 214 patients across 2 trials
Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s Disease
Start: Feb 2007Est. completion: Aug 2009214 patients
Phase 3Completed
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Start: Jan 2020Est. completion: Jun 2032
Phase 1Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials targeting 214 patients
2 companies competing in this space